Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2022-08-23

Clinical Trial Update: Benefit of Topical Hemostatic Powder Containing Hydrophilic Polymer With Potassium Ferrate for Hemostasis Following Nail Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial investigating topical hemostatic powder with hydrophilic polymer and potassium ferrate for nail surgery was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Nail Diseases | Phase 4 | Status: WITHDRAWN